Cargando…
Recombinant glucagon: a differential biological activity
In Brazil, there is a growing demand for specialised pharmaceuticals, and the high cost of their importation results in increasing costs, reaching US$ 1.34 billion in 2012 and US$ 1.61 billion in 2013. Worldwide expenses related to drugs could reach US$ 1.3 trillion in 2018, especially due to new tr...
Autores principales: | Basso, Angelina M M, Pelegrini, Patrícia B, Mulinari, Fernanda, Costa, Michelle C, Viana, Antonio B, Silva, Luciano P, Grossi-de-Sa, Maria Fatima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385203/ https://www.ncbi.nlm.nih.gov/pubmed/25852997 http://dx.doi.org/10.1186/s13568-015-0099-2 |
Ejemplares similares
-
Identification of a new binding protein in the insect-pest midgut Heliothis virescens that interacts with Cry1A toxins
por: Pelegrini, Patrícia, et al.
Publicado: (2014) -
Antibacterial Peptides from Plants: What They Are and How They Probably Work
por: Barbosa Pelegrini, Patrícia, et al.
Publicado: (2011) -
Plants as Sources of Natural and Recombinant Antimalaria Agents
por: Habibi, Peyman, et al.
Publicado: (2022) -
Revisiting the Pharmacological Value of Glucagon: An Editorial for the Special Issue “The Biology and Pharmacology of Glucagon”
por: Müller, Timo D., et al.
Publicado: (2020) -
Anti-parasitic Peptides from Arthropods and their Application in Drug Therapy
por: Lacerda, Ariane F., et al.
Publicado: (2016)